Stem Cell Market: Opportunities and Challenges -- New Report by Koncept Analytics

Jan. 24, 2011 - PRLog -- Stem cell biology is a promising and emerging field of the life sciences. Advances in biological sciences and the development of human stem cells are bringing new hope for the treatment of many diseases such as Parkinson’s disease, diabetes, heart diseases and cancer as well as injuries for which there has previously been no effective treatment. The medical stem cells market is divided into three categories: stem cell therapeutics, cord blood banking and drug development tools based on the application. Stem cell therapeutics account for a major portion of the market which has been boosted by recent technological breakthroughs that expanded the scope of therapeutic uses. North America is the largest market for stem cells for 2009 with a share of slightly over one-third of global market while Europe is projected to be the second largest and second fastest growing market.

US is the major stem cell market in the world and has recently been boosted by the decision on lifting the 8 years old ban on federal funding for embryonic stem cell research on March 2009. Despite of the technological and ethical challenges surrounding the utilization of embryonic stem cells, recent developments to grow human embryonic stem cells in culture and an increased understanding of the pathways of cell differentiation have expanded the horizon of likely therapeutic uses. In addition, rising patient population, demand for umbilical cord cell banking and transplantation have increased the demand for stem cells development.

The report broadly includes the following

1. Stem Cells: An Overview

1.1 Sources of Stem Cells
1.2 Applications of Stem Cells

2. Global Stem Cell Market

2.1 Market Size and Growth
2.2 Geographical Segmentation

3. The US Stem Cell Market

3.1 Market Overview
3.2 Market Size

4. Stem Cell Market:Key Drivers

5. Market Opportunities

6. Industry Challenges

7. Stem Cell:Market Outlook

8. Stem Cell: Company Analysis

8.1 Osiris Therapeutics Inc.
8.2 Cytori Therapeutics, Inc
8.3 ThermoGenesis Corp.
8.4 Neostem Inc.

List of Graphs

Stem Cell Discovery Timeline
Global Stem Cell Product Market (2006-2015E)
Category wise segmentation of Global Stem Cell Market (2015E)
Global Stem Cell Market by Therapeutic Areas (2010)
Breakdown by Global Stem Cell Technologies (2010)
Percentage Breakdown of Global Stem Cell Market by Geographic Region (2009)
US stem Cell Market by Therapeutic Area (2018E)
Segmentation of Types of Stem Cell Research on the basis of Funding (2008)
The US Stem Cell Market (2006-2010E)
Funding for Stem Cell Research (2005-2008)
Worldwide Total Cord Blood Banks (2005-2010)
US projected rise in chronic disease (2003-2023)
Worldwide Deaths due to Chronic Diseases (2008)
Stem Cell Research in India by Therapeutic Areas (2009)
Market Forecast for the US Stem Cell Market (2009E-2016E)
Annual Revenue of Osiris Therapeutics Inc (2005-2009)
Annual Revenues of Cytori Therapeutics Inc. (2005-2009)
Annual Revenue of ThermoGenesis Corp. (2006-2010)
Annual Revenues of NeoStem Inc. (2007-2009)

List of Tables

Comparison of Different Sources of Stem Cells
Units of Cord Blood Stem Cells Collected in Selective Countries (2008)
Funding for Stem Cell Research in the US (2005-2008)
Procedure Volume for Proprietary Stem Cell Therapies by Disease in Thousands (2012-2020)
Osiris Inc. Different Biologic Drug Candidates and its Status (2009)
Cytori Inc’s Current Products Along With Issued Patents
Cytori’s Future Generation Products in Development

For more details, please visit http://www.konceptanalytics.com/reportDetail.aspx?reportI...

To know more about us http://www.konceptanalytics.com/

# # #

Koncept Analytics, founded in 2005, works with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.